Evidence map›Paper›PMID 31324249›Full record

ArticleRadiation oncology (London, England)2019

Radiotherapy for recurrent central Giant cell granuloma: a case report.

Qi Zhang, Zelai He, Gengming Wang, Hao Jiang

Open access · goldAbstract readCase Reports
In one paragraph

Article in Radiation oncology (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. [Use of current imaging tools for the study of odontogenic myxoma. A review of the literature].Revista cientifica odontologica (Universidad Cientifica del Sur)
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Qi ZhangDepartment of Radiation Oncology, The First Affiliated Hospital of Bengbu Medical University and Tumor Hospital Affiliated to Bengbu Medical University, 287 Changhuai Road, Bengbu, Anhui, 233004, People's Republic of China.
Zelai HeDepartment of Radiation Oncology, The First Affiliated Hospital of Bengbu Medical University and Tumor Hospital Affiliated to Bengbu Medical University, 287 Changhuai Road, Bengbu, Anhui, 233004, People's Republic of China.
Gengming WangDepartment of Radiation Oncology, The First Affiliated Hospital of Bengbu Medical University and Tumor Hospital Affiliated to Bengbu Medical University, 287 Changhuai Road, Bengbu, Anhui, 233004, People's Republic of China.
Hao JiangDepartment of Radiation Oncology, The First Affiliated Hospital of Bengbu Medical University and Tumor Hospital Affiliated to Bengbu Medical University, 287 Changhuai Road, Bengbu, Anhui, 233004, People's Republic of China. jianghao1223@163.com.
Bengbu Medical College · CNFirst Affiliated Hospital of Bengbu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCentral giant cell granuloma (CGCG) is a rare, non-neoplastic, benign lesion that exhibits expansive and osteolytic biological behavior. CGCG treatment and management is challenging for clinicians. CASE PRESENTATION: This report presents the treatment and management of recurrent, aggressive CGCG after surgical resection. After informed consent was obtained, the patient underwent radiotherapy. The lesion size was reduced significantly, with no evidence of recurrence or malignant transformation.

conclusionsThis treatment experience indicates that radiotherapy can be used as a rescue treatment for complicated CGCG involving vital neurovascular structures of the cranial base.

Indexed as

AdultGranuloma, Giant CellHumansMaleMandibular DiseasesNasal CavityPrognosisRadiotherapy DosageRecurrenceCentral giant cell granulomaRadiotherapySurgical resection

Identifiers

PMID31324249
PMCPMC6642559
OpenAlexW2964268873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.